Eija Pelkonen appointed as Fimea’s Director-General
On 27 June 2018, the Government appointed Eija Pelkonen as Director-General of the Finnish Medicines Agency (Fimea).
She will take up the position on 1 October 2018. The appointment is for a fixed period until 30 September 2023.
Pelkonen has served as Director of Fimea’s Supervision and Licences Department since 2009. Before this, she worked as Head of the Inspectorate Unit at the National Agency for Medicines. In spring 2017, Pelkonen worked part time at Fimea and part time in the fixed-term position of Pharmaceutical Senior Specialist at the Ministry of Social Affairs and Health. She has also worked as Specialist at the National Agency for Medicines and as Quality Specialist at the Finnish Red Cross, among other positions. She holds the degree of Master of Science (Pharmacy).
The Director-General leads the activities of Fimea, is responsible for achieving the performance targets set for the agency, and ensures that the agency’s duties are managed effectively, economically and successfully. The Director-General monitors the development of Fimea’s field of activity and is in charge of the general development of the agency.
The Finnish Medicines Agency is a central agency under the Ministry of Social Affairs and Health. It promotes public health and safety by supervising medicinal products and blood and tissue products as well as by developing the pharmaceuticals field.
Nine candidates applied for the post as the Director-General of Fimea.
Päivi Sillanaukee, Permanent Secretary, tel. +358 2951 63356, email@example.com
Eija Pelkonen, tel. +358 50 511 17 56